Literature DB >> 2670514

Aspirin and thrombolytic therapy for acute myocardial infarction. Should the combination now be a routine therapy?

T L Schreiber1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2670514     DOI: 10.2165/00003495-198938020-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  8 in total

1.  Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

Authors:  R G Wilcox; G von der Lippe; C G Olsson; G Jensen; A M Skene; J R Hampton
Journal:  Lancet       Date:  1988-09-03       Impact factor: 79.321

Review 2.  Platelet-inhibitor drugs' role in coronary artery disease.

Authors:  V Fuster; P C Adams; J J Badimon; J H Chesebro
Journal:  Prog Cardiovasc Dis       Date:  1987 Mar-Apr       Impact factor: 8.194

3.  Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial.

Authors: 
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

4.  Superiority of warfarin over aspirin long term after thrombolytic therapy for acute myocardial infarction.

Authors:  T L Schreiber; D H Miller; D Silvasi; A McNulty; B E Zola
Journal:  Am Heart J       Date:  1990-06       Impact factor: 4.749

5.  Coronary angioscopy in patients with unstable angina pectoris.

Authors:  C T Sherman; F Litvack; W Grundfest; M Lee; A Hickey; A Chaux; R Kass; C Blanche; J Matloff; L Morgenstern
Journal:  N Engl J Med       Date:  1986-10-09       Impact factor: 91.245

6.  Aspirin inhibits platelet function independent of the acetylation of cyclo-oxygenase.

Authors:  M R Buchanan; J A Rischke; J Hirsh
Journal:  Thromb Res       Date:  1982-03-01       Impact factor: 3.944

7.  Effect of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. AIMS Trial Study Group.

Authors: 
Journal:  Lancet       Date:  1988-03-12       Impact factor: 79.321

8.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

  8 in total
  1 in total

Review 1.  Is aspirin underused in myocardial infarction?

Authors:  J M Arnau; A Agustí
Journal:  Pharmacoeconomics       Date:  1997-11       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.